on July 30, 2012 |
Permalink
Topics: Evidence-Based Practice, Methodologies, Performance Improvement, Cardiac Cath, Cardiovascular, Service Lines, Cardiac Surgery, Medical Cardiology
Nicole MacMillan, Cardiovascular Roundtable
Members have recently submitted several inquiries about guidelines, criteria, and clinical pathways for many cardiovascular conditions. The questions mainly surround heart failure, chest pain, atrial fibrillation, AMI/ PCI, and cardiac surgery.
Given the importance of standardizing CV operations across the care continuum and the growing concern over delivering the most appropriate treatments for patients, the Roundtable has compiled a number of helpful resources and sample CV pathways for our members' use.
We've collected three types of pathways organized by condition.
- Clinical guidelines
- Decision trees or patient pathways
- Triage criteria between observation units and admission to the ED
Continue reading:
Shedding light on cardiovascular practice guidelines, criteria, and pathways
on July 13, 2012 |
Permalink
Topics: Cardiac Cath, Cardiovascular, Service Lines, Appropriateness, Quality, Performance Improvement, Utilization, Efficiency, Evidence-Based Practice, Methodologies
Megan Tooley, Cardiovascular Roundtable
Reducing the use of drug-eluting stents (DES) in patients at low risk of restenosis would lead to significant cost savings with minimal increase in target vessel revascularization (TVR), according to a new retrospective analysis of the National Cardiovascular Data Registry (NCDR)-CathPCI published in the Archives of Internal Medicine.
This research contributes to the growing body of evidence supporting a risk-based, individualized approach to utilization of DES versus bare-metal stents (BMS) during percutaneous coronary intervention (PCI).
Continue reading:
Significant cost savings from more principled use of drug-eluting stents
on June 4, 2012 |
Permalink
Topics: Stroke, Cardiovascular, Service Lines, Evidence-Based Practice, Methodologies, Performance Improvement, Risk Stratification, Screening and Prevention
Megan Tooley, Cardiovascular Roundtable
Patients with a history of atherosclerotic ischemic stroke should be considered to be at high risk for subsequent cardiovascular disease (CVD), in particular, coronary heart disease (CHD), according to a new joint scientific statement released by the American Heart Association (AHA) and American Stroke Association (ASA).
These recommendations—the first U.S. guidelines to include stroke as a risk factor for coronary events—may require re-evaluation of current risk prediction algorithms and significantly increase the population of patients considered to be at high CV risk.
Continue reading:
Add stroke to list of CVD risk factors, new AHA/ASA statement recommends
